Posted inBiotechnology
Sharks Flourish in Prey-Rich Hotspots
In recent years, the conservation of shark populations has garnered significant scientific and public attention, largely due to the crucial…
Posted inGenetics
Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus
Measles virus, illustration. [Kateryna Kon/Science Photo Library/Getty Images] T cells are some of the immune system’s most important fighters. They…
Posted inGenetics
Fulcrum Halts Development of SCD Candidate Pociredir, Sets Strategic Review
Credit: EzumeImages / iStock / Getty Images Plus Fulcrum Therapeutics said today it is scrapping its lead pipeline program to…
Posted inBiotechnology
Brief Intensive Phototherapy for Newborns: Benefits, Risks
In the ever-evolving landscape of neonatal care, a recent publication by T.M. Slusher brings to the forefront an intriguing exploration…
Posted inBiotechnology
Rras2–BMPR2 Loop Drives Bone Growth, Targets Osteoporosis
In a groundbreaking study set to reshape osteoporosis treatment paradigms, researchers have unveiled a pivotal molecular feedback mechanism involving Rras2…
Posted inBiotechnology
WVU Study Finds Increased Movement and Reduced Sitting Linked to Healthier Pregnancies
A groundbreaking study conducted by researchers at West Virginia University (WVU) in collaboration with the University of Iowa and the…
Posted inBiotechnology
Combining Immunotherapy with Radiation Enhances Disease-Free Survival in Localized Prostate Cancer
In a groundbreaking multicenter clinical trial, scientists have determined that integrating an innovative adenoviral-based viral immunotherapy, known as aglatimagene besadenovec…
Posted inGenetics
Disease Detection Gets Boost from Keck’s New Brain Reference Map
Illustration of a high-resolution brain tractogram, depicting the complex network of neural pathways in the human brain. The intricate fibre…
Posted inBiotechnology
How Unlearn is building a scientific intelligence layer for clinical development
Sponsored By Unlearn Jun 8, 2026 8:00am Artificial intelligence is moving from a peripheral tool in clinical development into the…
Posted inBiotechnology
Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases
“We can probably edit almost any gene, but that doesn’t mean we should,” Dan Rosan, chief financial and business officer…